Your browser doesn't support javascript.
loading
Full Dose Cyclophosphamide with the Addition of Fludarabine for Matched Sibling Transplants in Severe Aplastic Anemia.
El Fakih, Riad; Alhayli, Saud; Ahmed, Syed Osman; Shaheen, Marwan; Chaudhri, Naeem; Alsharif, Fahad; Hanbali, Amr; Alfraih, Feras; Alshaibani, Alfadel; Assiri, Ali; Samarkandi, Hadeel; Babiker, Fatima; Alshomar, Ahmad; Alhakim, Anas; Ghabashi, Emad; Kotb, Ahmed; Elhassan, Tusneem; Balbaid, Ahmed; Alsadi, Husam; Rasheed, Walid; Alahmari, Ali; Alzahrani, Hazzaa; Almohareb, Fahad; Aljurf, Mahmoud.
Afiliación
  • El Fakih R; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. Electronic address: riadfakih@hotmail.com.
  • Alhayli S; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Ahmed SO; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Shaheen M; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Chaudhri N; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Alsharif F; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Hanbali A; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Alfraih F; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Alshaibani A; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Assiri A; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Samarkandi H; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Babiker F; Department of Medicine, Alfaisal University School of Medicine, Riyadh, Saudi Arabia.
  • Alshomar A; Department of Medicine, College of Medicine, Qassim University, Buraydah, Saudi Arabia.
  • Alhakim A; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Ghabashi E; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Kotb A; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Elhassan T; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Balbaid A; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Alsadi H; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Rasheed W; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Alahmari A; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Alzahrani H; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Almohareb F; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Aljurf M; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Transplant Cell Ther ; 27(10): 851.e1-851.e6, 2021 10.
Article en En | MEDLINE | ID: mdl-34126277
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anemia Aplásica Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Transplant Cell Ther Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anemia Aplásica Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Transplant Cell Ther Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos